IL-13

Industry

CPC
C07K14/5437

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07KPEPTIDES C07K14/00Peptides having more than 20 amino acids Gastrins Somatostatins Melanotropins Derivatives thereof

Current Industry

C07K14/5437IL-13

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
De novo design of potent and selective interleukin mimetics
- Patent number 12,227,553
- Issue date Feb 18, 2025
- University of Washington
- Daniel Adriano Silva Manzano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ligand discovery and gene delivery via retroviral surface display
- Patent number 12,222,347
- Issue date Feb 11, 2025
- Massachusetts Institute of Technology
- Michael Birnbaum
- G01 - MEASURING TESTING
Information Patent Grant
Ligand discovery and gene delivery via retroviral surface display
- Patent number 12,061,187
- Issue date Aug 13, 2024
- Massachusetts Institute of Technology
- Michael Birnbaum
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Ligand discovery and gene delivery via retroviral surface display
- Patent number 12,061,188
- Issue date Aug 13, 2024
- Massachusetts Institute of Technology
- Michael Birnbaum
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Therapeutic IL-13 polypeptides
- Patent number 11,993,639
- Issue date May 28, 2024
- The Board of Trustees of the Leland Stanford Junior University
- Kenan Christopher Garcia
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multi-level specific targeting of cancer cells
- Patent number 11,976,101
- Issue date May 7, 2024
- Wake Forest University Health Sciences
- Waldemar Debinski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Expression of metabolic modulators in tumor microenvironment to imp...
- Patent number 11,786,569
- Issue date Oct 17, 2023
- University of Pittsburgh of the Commonwealth System of Higher Education
- Greg M. Delgoffe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetically modified non-human animals expressing human EPO
- Patent number 11,766,032
- Issue date Sep 26, 2023
- REGENERON PHARMACEUTICALS, INC.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EPHA3 and multi-valent targeting of tumors
- Patent number 11,697,675
- Issue date Jul 11, 2023
- Wake Forest University Health Sciences
- Waldemar Debinski
- G01 - MEASURING TESTING
Information Patent Grant
Cancer stem cell targeted cancer vaccines
- Patent number 11,672,847
- Issue date Jun 13, 2023
- Stemline Therapeutics, Inc.
- Ivan Bergstein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
De novo design of potent and selective interleukin mimetics
- Patent number 11,655,278
- Issue date May 23, 2023
- University of Washington
- Daniel Adriano Silva Manzano
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treating fibrosis
- Patent number 11,547,738
- Issue date Jan 10, 2023
- Cedars-Sinai Medical Center
- Ramachandran Murali
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
De novo design of potent and selective interleukin mimetics
- Patent number 11,401,313
- Issue date Aug 2, 2022
- University of Washington
- Daniel Adriano Silva Manzano
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fusion protein comprising IL13
- Patent number 11,312,757
- Issue date Apr 26, 2022
- Synerkine Pharma B.V.
- Niels Eijkelkamp
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric immunoreceptor useful in treating human cancers
- Patent number 11,278,594
- Issue date Mar 22, 2022
- City of Hope
- Michael Jensen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Deimmunized therapeutic compositions and methods
- Patent number 11,208,634
- Issue date Dec 28, 2021
- Regents of The University of Minnesota
- Daniel Attilio Vallera
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multi-level specific targeting of cancer cells
- Patent number 11,136,367
- Issue date Oct 5, 2021
- Wake Forest University Health Sciences
- Waldemar Debinski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
De novo design of potent and selective interleukin mimetics
- Patent number 11,117,944
- Issue date Sep 14, 2021
- University of Washington
- Daniel Adriano Silva Manzano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic IL-13 polypeptides
- Patent number 11,084,858
- Issue date Aug 10, 2021
- The Board of Trustees of the Leland Stanford Junior University Stanford, CA
- Kenan Christopher Garcia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
De novo design of potent and selective interleukin mimetics
- Patent number 10,844,105
- Issue date Nov 24, 2020
- University of Washington
- Daniel Adriano Silva Manzano
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EPHA3 and multi-valent targeting of tumors
- Patent number 10,752,667
- Issue date Aug 25, 2020
- Wake Forest University Health Sciences
- Waldemar Debinski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
De novo design of potent and selective interleukin mimetics
- Patent number 10,703,791
- Issue date Jul 7, 2020
- University of Washington
- Daniel Adriano Silva Manzano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Costimulatory chimeric antigen receptor T cells targeting IL13Rα2
- Patent number 10,676,717
- Issue date Jun 9, 2020
- City of Hope
- Christine E. Brown
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Multi-level specific targeting of cancer cells
- Patent number 10,519,210
- Issue date Dec 31, 2019
- Wake Forest University Health Sciences
- Waldemar Debinski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fusion polypeptide in which anti-inflammatory polypeptide and ferri...
- Patent number 10,513,545
- Issue date Dec 24, 2019
- Kyungpook National University Industry-Academic Cooperation Foundation
- Jong-Sup Bae
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cancer stem cell targeted cancer vaccines
- Patent number 10,485,858
- Issue date Nov 26, 2019
- Stemline Therapeutics, Inc.
- Ivan Bergstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetically modified non-human animals expressing human EPO
- Patent number 10,463,028
- Issue date Nov 5, 2019
- REGENERON PHARMACEUTICALS, INC.
- Andrew J. Murphy
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Method to increase the number of circulating platelets by administe...
- Patent number 10,329,337
- Issue date Jun 25, 2019
- Bolder Biotechnology, Inc.
- George N. Cox
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytokine-based fusion proteins for treatment of immune disorders
- Patent number 10,273,284
- Issue date Apr 30, 2019
- East Carolina University
- Mark D. Mannie
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for treating fibrosis
- Patent number 10,245,298
- Issue date Apr 2, 2019
- Cedars-Sinai Medical Center
- Ramachandran Murali
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
IL-13RALPHA2 TARGETED IMMUNOTOXINS AND METHODS OF USE
- Publication number 20240239857
- Publication date Jul 18, 2024
- The United States of America, as represented by the Secretary, Dept. of Healt...
- Raj K. Puri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LIGAND DISCOVERY AND GENE DELIVERY VIA RETROVIRAL SURFACE DISPLAY
- Publication number 20240230627
- Publication date Jul 11, 2024
- Massachusetts Institute of Technology
- Michael Birnbaum
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARG...
- Publication number 20240189423
- Publication date Jun 13, 2024
- The Regents of the University of California
- James A. WELLS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cancer Stem Cell Targeted Cancer Vaccines
- Publication number 20240115677
- Publication date Apr 11, 2024
- STEMLINE THERAPEUTICS, INC.
- Ivan Bergstein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VIRUS-LIKE PARTICLES AND METHODS OF PRODUCTION THEREOF
- Publication number 20240093159
- Publication date Mar 21, 2024
- UNIVERSITY OF DUNDEE
- John FOERSTER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO
- Publication number 20240074414
- Publication date Mar 7, 2024
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
De Novo Design of Potent and Selective Interleukin Mimetics
- Publication number 20240076342
- Publication date Mar 7, 2024
- University of Washington
- Daniel Adriano Silva Manzano
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LIGAND DISCOVERY AND GENE DELIVERY VIA RETROVIRAL SURFACE DISPLAY
- Publication number 20240044873
- Publication date Feb 8, 2024
- Massachusetts Institute of Technology
- Michael Birnbaum
- G01 - MEASURING TESTING
Information Patent Application
DUAL-TARGETING CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS COMPRISIN...
- Publication number 20230374085
- Publication date Nov 23, 2023
- CITY OF HOPE
- Christine E. Brown
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING GLIOBLASTOMA
- Publication number 20230322894
- Publication date Oct 12, 2023
- The Regents of the University of California
- Yvonne Yu-Hsuan CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CELLULOSE BINDING DOMAIN (CBD) CELL EFFECTOR PROTEIN (CEP) CHIMERA,...
- Publication number 20230303982
- Publication date Sep 28, 2023
- BIOBETTER LTD.
- Oded Shoseyov
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Application
EPHA3 AND MULTI-VALENT TARGETING OF TUMORS
- Publication number 20230272033
- Publication date Aug 31, 2023
- Wake Forest University Health Sciences
- Waldemar Debinski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Interleukin-9 Signaling in Chimeric Antigen Receptor (CAR) Immune C...
- Publication number 20230265147
- Publication date Aug 24, 2023
- The Trustees of the University of Pennsylvania
- Mikko SIURALA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
De Novo Design of Potent and Selective Interleukin Mimetics
- Publication number 20220235110
- Publication date Jul 28, 2022
- University of Washington
- Daniel Adriano Silva Manzano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEIN COMPRISING IL13
- Publication number 20220220179
- Publication date Jul 14, 2022
- Synerkine Pharma B.V.
- Niels EIJKELKAMP
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
De Novo Design of Potent and Selective Interleukin Mimetics
- Publication number 20220056095
- Publication date Feb 24, 2022
- University of Washington
- Daniel Adriano Silva Manzano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTI-LEVEL SPECIFIC TARGETING OF CANCER CELLS
- Publication number 20210395324
- Publication date Dec 23, 2021
- Wake Forest University Health Sciences
- Waldemar Debinski
- G01 - MEASURING TESTING
Information Patent Application
Administration of Engineered T Cells for Treatment of Cancers in th...
- Publication number 20210244761
- Publication date Aug 12, 2021
- CITY OF HOPE
- Behnam Badie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-13/IL-4 SUPERKINES: IMMUNE CELL TARGETING CONSTRUCTS AND METHODS...
- Publication number 20210214410
- Publication date Jul 15, 2021
- The Board of Trustees of the Leland Stanford Junior University
- Kenan Christopher Garcia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEIN COMPRISING IL13
- Publication number 20210214411
- Publication date Jul 15, 2021
- Synerkine Pharma B.V.
- Niels EIJKELKAMP
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOREACTANT CARRIER
- Publication number 20210177988
- Publication date Jun 17, 2021
- LEMONEX INC.
- Cheol Hee WON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cancer Stem Cell Targeted Cancer Vaccines
- Publication number 20210093701
- Publication date Apr 1, 2021
- STEMLINE THERAPEUTICS, INC.
- Ivan Bergstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CELL-TYPE SPECIFIC EXOSOMES AND USE THEREOF
- Publication number 20210030807
- Publication date Feb 4, 2021
- BRAINSTORM CELL THERAPEUTICS LTD.
- Revital ARICHA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-13 RECEPTOR ALPHA 2 TARGETED, ZETAKINE DIRECTED T CELL IMMUNOTHE...
- Publication number 20210017246
- Publication date Jan 21, 2021
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Giacomo Tampella
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel IL-4-/IL-13-derived peptide compounds for the treatment or pr...
- Publication number 20200377568
- Publication date Dec 3, 2020
- Christina Francisca Vogelaar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LIGAND DISCOVERY AND GENE DELIVERY VIA RETROVIRAL SURFACE DISPLAY
- Publication number 20200371088
- Publication date Nov 26, 2020
- Massachusetts Institute of Technology
- Michael Birnbaum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chimeric Immunoreceptor Useful in Treating Human Cancers
- Publication number 20200353051
- Publication date Nov 12, 2020
- CITY OF HOPE
- Michael C. Jensen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EPHA3 AND MULTI-VALENT TARGETING OF TUMORS
- Publication number 20200347113
- Publication date Nov 5, 2020
- Wake Forest University Health Sciences
- Waldemar Debinski
- G01 - MEASURING TESTING
Information Patent Application
De Novo Design of Potent and Selective Interleukin Mimetics
- Publication number 20200347109
- Publication date Nov 5, 2020
- University of Washington
- Daniel Adriano Silva Manzano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXPRESSION OF METABOLIC MODULATORS IN TUMOR MICROENVIRONMENT TO IMP...
- Publication number 20200330534
- Publication date Oct 22, 2020
- University of Pittsburgh of the Commonwealth System of Higher Education
- Greg M. Delgoffe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

De novo design of potent and selective interleukin mimetics

Ligand discovery and gene delivery via retroviral surface display

Ligand discovery and gene delivery via retroviral surface display

Ligand discovery and gene delivery via retroviral surface display

Therapeutic IL-13 polypeptides

Multi-level specific targeting of cancer cells

Expression of metabolic modulators in tumor microenvironment to imp...

Genetically modified non-human animals expressing human EPO

EPHA3 and multi-valent targeting of tumors

Cancer stem cell targeted cancer vaccines

De novo design of potent and selective interleukin mimetics

Compositions and methods for treating fibrosis

De novo design of potent and selective interleukin mimetics

Fusion protein comprising IL13

Chimeric immunoreceptor useful in treating human cancers

Deimmunized therapeutic compositions and methods

Multi-level specific targeting of cancer cells

De novo design of potent and selective interleukin mimetics

Therapeutic IL-13 polypeptides

De novo design of potent and selective interleukin mimetics

EPHA3 and multi-valent targeting of tumors

De novo design of potent and selective interleukin mimetics

Costimulatory chimeric antigen receptor T cells targeting IL13Rα2

Multi-level specific targeting of cancer cells

Fusion polypeptide in which anti-inflammatory polypeptide and ferri...

Cancer stem cell targeted cancer vaccines

Genetically modified non-human animals expressing human EPO

Method to increase the number of circulating platelets by administe...

Cytokine-based fusion proteins for treatment of immune disorders

Compositions and methods for treating fibrosis

Patents Applicationslast 30 patents

IL-13RALPHA2 TARGETED IMMUNOTOXINS AND METHODS OF USE

LIGAND DISCOVERY AND GENE DELIVERY VIA RETROVIRAL SURFACE DISPLAY

BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARG...

Cancer Stem Cell Targeted Cancer Vaccines

VIRUS-LIKE PARTICLES AND METHODS OF PRODUCTION THEREOF

GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO

De Novo Design of Potent and Selective Interleukin Mimetics

LIGAND DISCOVERY AND GENE DELIVERY VIA RETROVIRAL SURFACE DISPLAY

DUAL-TARGETING CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS COMPRISIN...

METHODS AND COMPOSITIONS FOR TREATING GLIOBLASTOMA

CELLULOSE BINDING DOMAIN (CBD) CELL EFFECTOR PROTEIN (CEP) CHIMERA,...

EPHA3 AND MULTI-VALENT TARGETING OF TUMORS

Interleukin-9 Signaling in Chimeric Antigen Receptor (CAR) Immune C...

De Novo Design of Potent and Selective Interleukin Mimetics

FUSION PROTEIN COMPRISING IL13

De Novo Design of Potent and Selective Interleukin Mimetics

MULTI-LEVEL SPECIFIC TARGETING OF CANCER CELLS

Administration of Engineered T Cells for Treatment of Cancers in th...

IL-13/IL-4 SUPERKINES: IMMUNE CELL TARGETING CONSTRUCTS AND METHODS...

FUSION PROTEIN COMPRISING IL13

IMMUNOREACTANT CARRIER

Cancer Stem Cell Targeted Cancer Vaccines

CELL-TYPE SPECIFIC EXOSOMES AND USE THEREOF

IL-13 RECEPTOR ALPHA 2 TARGETED, ZETAKINE DIRECTED T CELL IMMUNOTHE...

Novel IL-4-/IL-13-derived peptide compounds for the treatment or pr...

LIGAND DISCOVERY AND GENE DELIVERY VIA RETROVIRAL SURFACE DISPLAY

Chimeric Immunoreceptor Useful in Treating Human Cancers

EPHA3 AND MULTI-VALENT TARGETING OF TUMORS

De Novo Design of Potent and Selective Interleukin Mimetics

EXPRESSION OF METABOLIC MODULATORS IN TUMOR MICROENVIRONMENT TO IMP...